Armistice Capital, LLC Agios Pharmaceuticals, Inc. Transaction History
Armistice Capital, LLC
- $6.02 Billion
- Q3 2024
A detailed history of Armistice Capital, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,207,070 shares of AGIO stock, worth $121 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
2,207,070
Previous 2,079,151
6.15%
Holding current value
$121 Million
Previous $89.7 Million
9.38%
% of portfolio
1.63%
Previous 1.17%
Shares
9 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$309 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$303 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$265 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$204 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$155 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.99B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...